Percutaneous Coronary Angioplasty in Patients with Cancer: Clinical Challenges and Management Strategies

Mamas

doi:10.3390/jpm12091372

Percutaneous Coronary Angioplasty in Patients with Cancer: Clinical Challenges and Management Strategies

Mamas

Authors

Mamas Mamas m.mamas@keele.ac.uk

Abstract

<jats:p>The number of cancer survivors in the United States is projected to increase by 31% by 2030. With advances in early screening, diagnosis and therapeutic strategies, a steadily increasing number of patients are surviving cancer. Coronary artery disease (CAD) is now one of the leading causes of death amongst cancer survivors, with the latter group of patients having a higher risk of CAD compared to the general population. Our review covers a range of specific challenges faced by doctors when considering percutaneous coronary interventions (PCI) in cancer patients; clinical outcomes in cancer patients undergoing PCI, as well as some important technical considerations to be made when making decisions regarding the management strategy in this special population of patients.</jats:p>

Acceptance Date	Aug 23, 2022
Publication Date	Aug 25, 2022
Journal	Journal of Personalized Medicine
Publisher	MDPI
Pages	1372 - 1372
DOI	https://doi.org/10.3390/jpm12091372
Keywords	cancer; percutaneous coronary angioplasty; coronary artery disease; outcome
Publisher URL	https://www.mdpi.com/2075-4426/12/9/1372